DiscoverX BioMAP® Phenotypic Profiling Services
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients…
BioMAP® is the only primary cell based screening platform that models human disease in vitro. The BioMAP® service offers over 50 biologically relevant systems and promises to deliver actionable data for better drug development decision making.
BioMAP® provides insights into mechanism of action, compound efficacy and safety-related effects, and enables the correlation of compound activity with clinical outcomes.
Downloads
Learn More
Click here to find out more via email
Related content from this organisation
Related topics
Assays, Drug Discovery Processes, Drug Targets, Informatics, Screening, Translational Science
Related organisations
DiscoverX Corporation
